These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 24723692)

  • 1. Resistance of naturally secreted α-synuclein to proteolysis.
    Ximerakis M; Pampalakis G; Roumeliotis TI; Sykioti VS; Garbis SD; Stefanis L; Sotiropoulou G; Vekrellis K
    FASEB J; 2014 Jul; 28(7):3146-58. PubMed ID: 24723692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KLK6 proteolysis is implicated in the turnover and uptake of extracellular alpha-synuclein species.
    Pampalakis G; Sykioti VS; Ximerakis M; Stefanakou-Kalakou I; Melki R; Vekrellis K; Sotiropoulou G
    Oncotarget; 2017 Feb; 8(9):14502-14515. PubMed ID: 27845893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficiency of the serine peptidase Kallikrein 6 does not affect the levels and the pathological accumulation of a-synuclein in mouse brain.
    Samantha Sykioti V; Karampetsou M; Chalatsa I; Polissidis A; Michael IP; Pagaki-Skaliora M; Nagy A; Emmanouilidou E; Sotiropoulou G; Vekrelli S K
    J Neurochem; 2021 Jun; 157(6):2024-2038. PubMed ID: 32974895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cleavage of normal and pathological forms of alpha-synuclein by neurosin in vitro.
    Kasai T; Tokuda T; Yamaguchi N; Watanabe Y; Kametani F; Nakagawa M; Mizuno T
    Neurosci Lett; 2008 May; 436(1):52-6. PubMed ID: 18358605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational properties of the SDS-bound state of alpha-synuclein probed by limited proteolysis: unexpected rigidity of the acidic C-terminal tail.
    de Laureto PP; Tosatto L; Frare E; Marin O; Uversky VN; Fontana A
    Biochemistry; 2006 Sep; 45(38):11523-31. PubMed ID: 16981712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo modulation of polo-like kinases supports a key role for PLK2 in Ser129 α-synuclein phosphorylation in mouse brain.
    Bergeron M; Motter R; Tanaka P; Fauss D; Babcock M; Chiou SS; Nelson S; San Pablo F; Anderson JP
    Neuroscience; 2014 Jan; 256():72-82. PubMed ID: 24128992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific pesticide-dependent increases in α-synuclein levels in human neuroblastoma (SH-SY5Y) and melanoma (SK-MEL-2) cell lines.
    Chorfa A; Bétemps D; Morignat E; Lazizzera C; Hogeveen K; Andrieu T; Baron T
    Toxicol Sci; 2013 Jun; 133(2):289-97. PubMed ID: 23535362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the mechanism of internalization of alpha-synuclein into microglia: roles of ganglioside GM1 and lipid raft.
    Park JY; Kim KS; Lee SB; Ryu JS; Chung KC; Choo YK; Jou I; Kim J; Park SM
    J Neurochem; 2009 Jul; 110(1):400-11. PubMed ID: 19457104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct interaction of α-synuclein and AKT regulates IGF-1 signaling: implication of Parkinson disease.
    Chung JY; Lee SJ; Lee SH; Jung YS; Ha NC; Seol W; Park BJ
    Neurosignals; 2011; 19(2):86-96. PubMed ID: 21474915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-synuclein interferes with cAMP/PKA-dependent upregulation of dopamine β-hydroxylase and is associated with abnormal adaptive responses to immobilization stress.
    Kim S; Park JM; Moon J; Choi HJ
    Exp Neurol; 2014 Feb; 252():63-74. PubMed ID: 24252179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond α-synuclein transfer: pathology propagation in Parkinson's disease.
    Hansen C; Li JY
    Trends Mol Med; 2012 May; 18(5):248-55. PubMed ID: 22503115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular neurosin degrades α-synuclein in cultured cells.
    Tatebe H; Watanabe Y; Kasai T; Mizuno T; Nakagawa M; Tanaka M; Tokuda T
    Neurosci Res; 2010 Aug; 67(4):341-6. PubMed ID: 20403393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of post-translational modifications in modulating the structure, function and toxicity of alpha-synuclein: implications for Parkinson's disease pathogenesis and therapies.
    Oueslati A; Fournier M; Lashuel HA
    Prog Brain Res; 2010; 183():115-45. PubMed ID: 20696318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-synuclein overexpression increases phospho-protein phosphatase 2A levels via formation of calmodulin/Src complex.
    Yang W; Wang X; Duan C; Lu L; Yang H
    Neurochem Int; 2013 Sep; 63(3):180-94. PubMed ID: 23796501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-synuclein and Parkinson's disease.
    Recchia A; Debetto P; Negro A; Guidolin D; Skaper SD; Giusti P
    FASEB J; 2004 Apr; 18(6):617-26. PubMed ID: 15054084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissecting the Molecular Pathway Involved in PLK2 Kinase-mediated α-Synuclein-selective Autophagic Degradation.
    Dahmene M; Bérard M; Oueslati A
    J Biol Chem; 2017 Mar; 292(9):3919-3928. PubMed ID: 28154193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular insights into the interaction between alpha-synuclein and docosahexaenoic acid.
    De Franceschi G; Frare E; Bubacco L; Mammi S; Fontana A; de Laureto PP
    J Mol Biol; 2009 Nov; 394(1):94-107. PubMed ID: 19747490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitive fluorescence polarization technique for rapid screening of alpha-synuclein oligomerization/fibrillization inhibitors.
    Luk KC; Hyde EG; Trojanowski JQ; Lee VM
    Biochemistry; 2007 Nov; 46(44):12522-9. PubMed ID: 17927212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson's disease.
    El-Agnaf OM; Salem SA; Paleologou KE; Curran MD; Gibson MJ; Court JA; Schlossmacher MG; Allsop D
    FASEB J; 2006 Mar; 20(3):419-25. PubMed ID: 16507759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of Ser129 phosphorylation of α-synuclein in neurodegeneration of Parkinson's disease: a review of in vivo models.
    Sato H; Kato T; Arawaka S
    Rev Neurosci; 2013; 24(2):115-23. PubMed ID: 23314528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.